Dr. Qiqi Deng is a Director in Clinical Biostatistics at Moderna. She leads a group focusing on clinical development of public health and latent virus vaccines, as well as statistical research. Before joining Moderna, she worked in Boehringer Ingelheim for thirteen years, with seven years serving as leading statistician for multiple projects, across different clinical development phases and therapeutic areas. After that, she worked as a methodology statistician for six years, with focus on statistical methodology innovation globally. Her main research area includes hypothesis testing and modeling in dose finding, adaptive design, and pragmatic considerations in applying innovative methodology into real clinical studies. She publishes on wide array of statistical topics in her main area and beyond, e.g. multiplicity adjustment, Bayesian statistics. Dr. Deng received her bachelor’s degree in Mathematics from Peking University in China, and obtained her Ph. D. in Statistics from University of Minnesota.